GNI Group to Acquire Ayumi Pharmaceutical Holdings in Full Buyout (BX)
What happened
GNI Group has announced a definitive agreement to acquire Ayumi Pharmaceutical Holdings, which GNI framed as part of its broader biopharmaceutical expansion strategy. The announcement, dated June 7, 2026, was released via GlobeNewswire. No transaction price was disclosed in the release headline. The transaction is being tracked under BX coverage given prior market reporting linking Blackstone to Ayumi's ownership structure; the GlobeNewswire release itself does not name Blackstone.
The QL Read
BX's QuantLogix composite sits at a neutral 43/100 with shares at $114.69, down 0.59% on the day. Any subsequent confirmation of a Blackstone exit or realization tied to Ayumi could influence the momentum factor, which currently reads mid-range.
Not financial advice. QuantLogix is a research platform; nothing in this brief constitutes a recommendation to buy or sell any security. We summarize public news with attribution to the original publisher; visit the source above for the full original article.